BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8173162)

  • 1. [Adenocarcinoma of the ovary as a study model of cancers and their treatments].
    Belpomme D; Filippi MH; Le Bonniec M; Héritier F
    Bull Cancer; 1993 Feb; 80(2):115-20. PubMed ID: 8173162
    [No Abstract]   [Full Text] [Related]  

  • 2. Raynaud's phenomenon as a presenting sign of ovarian adenocarcinoma.
    Paira SO
    J Rheumatol; 1996 Apr; 23(4):792. PubMed ID: 8730154
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer of the ovary.
    Cannistra SA
    N Engl J Med; 1993 Nov; 329(21):1550-9. PubMed ID: 8155119
    [No Abstract]   [Full Text] [Related]  

  • 4. [Ovarian cancer].
    Langmár Z; Csömör S; Németh M; Tomcsik Z; Joó JG
    Orv Hetil; 2011 Dec; 152(49):1977-84. PubMed ID: 22106167
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analytical studies on the treatment of adenocarcinoma of the ovary].
    Matsumoto Y; Kasamatsu T; Sonoda T; Ohmi K; Tsunematsu R; Tanemura K; Yamada T; Kishi K
    Nihon Gan Chiryo Gakkai Shi; 1984 May; 19(4):778-88. PubMed ID: 6491429
    [No Abstract]   [Full Text] [Related]  

  • 6. Continued controversies in the diagnosis and treatment of ovarian adenocarcinomas.
    Piver MS
    J Reprod Med; 1979 Mar; 22(3):119-27. PubMed ID: 108399
    [No Abstract]   [Full Text] [Related]  

  • 7. An atypical presentation of ovarian cancer.
    Moustafa M; Beynon WB
    J Obstet Gynaecol; 2002 Jul; 22(4):455-6. PubMed ID: 12521490
    [No Abstract]   [Full Text] [Related]  

  • 8. [Remote results of the standard ovary cancer treatment].
    Ushakov II; Mel'ko AI; Kira EF; Ermolinskiĭ II
    Voen Med Zh; 2005 Nov; 326(11):36-8. PubMed ID: 16404905
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ovarian carcinoma in the elderly; a diagnostic and therapeutic dilemma].
    Wymenga AN; Willemse PH; Aalders JG; Sleijfer DT
    Ned Tijdschr Geneeskd; 1996 Mar; 140(12):650-3. PubMed ID: 8668237
    [No Abstract]   [Full Text] [Related]  

  • 10. [Cancer of the ovary].
    Lhomme C; Slagmulder N; Bussy C; Lopez C; Droz JP
    Rev Infirm; 1991 Nov; 41(17):39-43. PubMed ID: 1767221
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cancers of the ovary].
    Antoine JM
    Soins Gynecol Obstet Pueric Pediatr; 1984; (37-38):18-21. PubMed ID: 6566477
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone metastasis as the presenting complaint in ovarian carcinoma.
    Kingston R; Sparkes J; Leen E; Stafford-Johnson D; Keogh P
    Acta Obstet Gynecol Scand; 2001 Jul; 80(7):669-70. PubMed ID: 11437731
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of early ovarian cancer.
    Young RC; Pecorelli S
    Semin Oncol; 1998 Jun; 25(3):335-9. PubMed ID: 9633845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian germ cell tumors: an update.
    Williams SD
    Semin Oncol; 1998 Jun; 25(3):407-13. PubMed ID: 9633853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New developments in the management of ovarian cancer.
    Hoskins WJ
    J Med Assoc Ga; 2003; 92(1):23-6, 33. PubMed ID: 12743902
    [No Abstract]   [Full Text] [Related]  

  • 16. Raynaud's phenomenon as a presenting sign of ovarian adenocarcinoma.
    Kohli M; Bennett RM
    J Rheumatol; 1995 Jul; 22(7):1393-4. PubMed ID: 7562782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodal therapy for esophageal adenocarcinoma.
    Funk EM; Witte J
    N Engl J Med; 1997 Jan; 336(5):375; author reply 375-6. PubMed ID: 9011795
    [No Abstract]   [Full Text] [Related]  

  • 18. Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management.
    Grønlund B
    Dan Med Bull; 2006 Aug; 53(3):232-57. PubMed ID: 17092448
    [No Abstract]   [Full Text] [Related]  

  • 19. [Current possibilities of the diagnosis and treatment of malignant ovarian tumors and trends in the development of the problem].
    Nechaeva ID
    Vopr Onkol; 1984; 30(12):67-74. PubMed ID: 6516278
    [No Abstract]   [Full Text] [Related]  

  • 20. Efficacy of intraperitoneal continuous hyperthermic chemotherapy as consolidation therapy in patients with advanced epithelial ovarian cancer: a long-term follow-up.
    Yoshida Y; Sasaki H; Kurokawa T; Kawahara K; Shukunami K; Katayama K; Yamaguchi A; Kotsuji F
    Oncol Rep; 2005 Jan; 13(1):121-5. PubMed ID: 15583812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.